LOGO
LOGO

Breaking News

Simulations Plus Shares Climb On Higher Q2 Results; Cuts FY26 Earnings View

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us

Shares of Simulations Plus, Inc. (SLP) were gaining around 14 percent in the pre-market activity on the Nasdaq after the provider of software and consulting services in biopharma sector reported higher earnings for the second quarter, attributed by overall topline growth.

Meanwhile, the company trimmed its fiscal 2026 adjusted earnings per share forecast, to reflect an increase in the expected effective tax rate for fiscal 2026.

For the second quarter, net income attributable to ordinary shareholders was $4.54 million or $0.22 per share, compared to $3.07 million or $0.15 per share in the same quarter of last year.

On an adjusted basis, net income was $7.03 million or $0.35 per share, compared to $6.20 million or $0.31 a year earlier.

Quarterly net revenue increased 8 percent to $24.29 million from $22.43 million a year before.

Looking ahead to the fiscal 2026, the company now expects adjusted earnings per share to be $0.75 to $0.85, lower than previously expected range of $1.03 - $1.10.

Further, the company continues to expect annual revenue to range between $79 million and $82 million, a growth of 0 percent to 4 percent year-over-year.

In pre-market activity on the Nasdaq, shares of Simulations were gaining around 13.78 percent, trading at $14.78, after closing Thursday's regular trading 0.08 percent lower.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.

For comments and feedback contact: editorial@rttnews.com

Business News

Looking to Invest in the Best Biotech Stocks? Subscribe to RTT Biotech Investor.
Global Economics Weekly Update -May 18 – May 22, 2026

May 22, 2026 14:46 ET
Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.

RELATED NEWS
Latest Updates on COVID-19